Is your continuous manufacturing line equipped to handle highly potent products?
Modern pharmaceutical machinery is designed to operate in a completely dust-tight manner. Striving to constantly improve our equipment, however, and ensure that it’s both contained and highly potent compatible, we operate a stringent testing program, according to SMEPAC guidelines.
Nevertheless, it’s absolutely critical to be fully prepared for worst-case scenarios. Product loss and downtime can be costly. More seriously, exposing personnel to toxic or highly potent dust could be catastrophic. The GEA BUCK® Digital Canary atmosphere monitoring system is designed to prevent this.
Contained Coating
SMEPAC trials have shown the GEA Tablet Coater is capable of handling highly potent pharmaceutical API and offers exceptional containment
Containment Monitoring
Digital Canary protects pharmaceutical plant, processes and operators by detecting breaches in contained production lines
Customer Story
Read the story of Chinoin, an early adopter of continuous processing equipment.
Review of 2022
In his final act as Director of Pharma Solids Sales at GEA Pharma and Healthcare, Richard Steiner, reflects on another record-breaking year for the company’s ConsiGma® 4.0 continuous manufacturing product line for the pharmaceutical industry.
Spotlight - the Road to Conti
During the Spotlight event discussing the road to continuous manufacturing, Mexican generics company, Chinion, joined our expert panel at Achema 2022 to share their experiences
Spotlight - Conti, Cleaning and Containment
At Achema 2022, one of the Spotlight events discussed the interaction between continuous manufacturing, cleaning and containment.
